TABLE 2.
Life table analysis of percentage of patients developing cidofovir resistance
| IC50 and culture source (n = 13) | % of patients for time on therapy (mo)
|
|||
|---|---|---|---|---|
| 3 | 6 | 9 | 12 | |
| >2 μM | ||||
| Blood | 20 | 20 | 20 | 100a |
| Urine | 8 | 8 | 8 | 8 |
| Blood or urine | 29 | 29 | 29 | 100 |
| >2.5 μM | ||||
| Blood | 20 | 20 | 20 | 20 |
| Urine | 0 | 0 | 0 | 0 |
| Blood or urine | 20 | 20 | 20 | 20 |
Only one patient remained on cidofovir beyond 6 months.